Skip to main navigation Skip to search Skip to main content

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

  • Flores Weverling
  • , Mieke Roeven
  • , Clara Nijssen
  • , Annoek E. C. Broers
  • , Elisabeth Dovern
  • , Anna van Rhenen
  • , Geerte van Sluis
  • , Carin L. E. Hazenberg
  • , Peter van Balen
  • , Maria T. Kuipers
  • , Karen M. K. de Vooght
  • , Linde Morsink
  • , J. rgen Kuball
  • , Erfan Nur
  • , Moniek A. de Witte*
  • *Corresponding author for this work
  • University Medical Center Utrecht
  • Radboud University Medical Center
  • Erasmus University Rotterdam
  • Isala Clinics
  • University of Groningen, University Medical Center Groningen
  • Leiden University Medical Center

Research output: Contribution to journalComment/Letter to the editorAcademic

21 Downloads (Pure)
Original languageEnglish
Pages (from-to)1683-1686
Number of pages4
JournalBlood advances
Volume8
Issue number7
DOIs
Publication statusPublished - 9 Apr 2024

Cite this